iShares MSCI EM ex China UCITS ETF USD Acc EUR is a equity ETF from iShares tracking the MSCI EM ex China index through physical replication. Domiciled in Ireland and launched in 2021, the fund manages about 4.7 bn € and charges a TER of 0.18% — 18 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
iShares MSCI EM ex China UCITS ETF USD Acc EUR competes with 1 other products on the same index (MSCI EM ex China): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.18% against a group median of 0.21%. It has been listed since 2021, 5 years of track record.
On a €10,000 investment the TER costs 18 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 48.8% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| Taiwan Semiconductor Manufacturing Co. Ltd. | 18.6% |
| Samsung Electronics Co Ltd | 10.1% |
| SK Hynix Inc | 9.4% |
| iShares MSCI Brazil UCITS ETF (DE) | 4.7% |
| MediaTek Inc | 1.9% |
| Delta Electronics Inc | 1.2% |
| SK Square Co Ltd | 1.0% |
| Hon Hai Precision Industry Co Ltd | 1.0% |
| HDFC Bank Limited | 0.9% |
| Borsa Italiana | EXCH | EUR |
| XETRA | 84X0 | EUR |
| London Stock Exchange | EXCS | GBP |
| Euronext Paris | MTPI | EUR |
| Euronext Amsterdam | EXCH | USD |
| SIX Swiss Exchange | EXCH | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.